Copyright Reports & Markets. All rights reserved.

Global Cell and Gene Therapy CRO Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Cell and Gene Therapy CRO Service
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cell and Gene Therapy CRO Service by Type
    • 1.3.1 Overview: Global Cell and Gene Therapy CRO Service Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Cell and Gene Therapy CRO Service Consumption Value Market Share by Type in 2022
    • 1.3.3 Preclinical CRO
    • 1.3.4 Clinical Stage CRO
    • 1.3.5 Others
  • 1.4 Global Cell and Gene Therapy CRO Service Market by Application
    • 1.4.1 Overview: Global Cell and Gene Therapy CRO Service Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Research Institute
    • 1.4.4 Others
  • 1.5 Global Cell and Gene Therapy CRO Service Market Size & Forecast
  • 1.6 Global Cell and Gene Therapy CRO Service Market Size and Forecast by Region
    • 1.6.1 Global Cell and Gene Therapy CRO Service Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Cell and Gene Therapy CRO Service Market Size by Region, (2018-2029)
    • 1.6.3 North America Cell and Gene Therapy CRO Service Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Cell and Gene Therapy CRO Service Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Cell and Gene Therapy CRO Service Market Size and Prospect (2018-2029)
    • 1.6.6 South America Cell and Gene Therapy CRO Service Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Cell and Gene Therapy CRO Service Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 PPD
    • 2.1.1 PPD Details
    • 2.1.2 PPD Major Business
    • 2.1.3 PPD Cell and Gene Therapy CRO Service Product and Solutions
    • 2.1.4 PPD Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 PPD Recent Developments and Future Plans
  • 2.2 Medpace
    • 2.2.1 Medpace Details
    • 2.2.2 Medpace Major Business
    • 2.2.3 Medpace Cell and Gene Therapy CRO Service Product and Solutions
    • 2.2.4 Medpace Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Medpace Recent Developments and Future Plans
  • 2.3 Labcorp
    • 2.3.1 Labcorp Details
    • 2.3.2 Labcorp Major Business
    • 2.3.3 Labcorp Cell and Gene Therapy CRO Service Product and Solutions
    • 2.3.4 Labcorp Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Labcorp Recent Developments and Future Plans
  • 2.4 Veristat
    • 2.4.1 Veristat Details
    • 2.4.2 Veristat Major Business
    • 2.4.3 Veristat Cell and Gene Therapy CRO Service Product and Solutions
    • 2.4.4 Veristat Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Veristat Recent Developments and Future Plans
  • 2.5 Charles River Laboratories
    • 2.5.1 Charles River Laboratories Details
    • 2.5.2 Charles River Laboratories Major Business
    • 2.5.3 Charles River Laboratories Cell and Gene Therapy CRO Service Product and Solutions
    • 2.5.4 Charles River Laboratories Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.6 Premier Research
    • 2.6.1 Premier Research Details
    • 2.6.2 Premier Research Major Business
    • 2.6.3 Premier Research Cell and Gene Therapy CRO Service Product and Solutions
    • 2.6.4 Premier Research Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Premier Research Recent Developments and Future Plans
  • 2.7 Catalent
    • 2.7.1 Catalent Details
    • 2.7.2 Catalent Major Business
    • 2.7.3 Catalent Cell and Gene Therapy CRO Service Product and Solutions
    • 2.7.4 Catalent Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Catalent Recent Developments and Future Plans
  • 2.8 IQVIA
    • 2.8.1 IQVIA Details
    • 2.8.2 IQVIA Major Business
    • 2.8.3 IQVIA Cell and Gene Therapy CRO Service Product and Solutions
    • 2.8.4 IQVIA Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 IQVIA Recent Developments and Future Plans
  • 2.9 Vial
    • 2.9.1 Vial Details
    • 2.9.2 Vial Major Business
    • 2.9.3 Vial Cell and Gene Therapy CRO Service Product and Solutions
    • 2.9.4 Vial Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Vial Recent Developments and Future Plans
  • 2.10 Noble Life Sciences
    • 2.10.1 Noble Life Sciences Details
    • 2.10.2 Noble Life Sciences Major Business
    • 2.10.3 Noble Life Sciences Cell and Gene Therapy CRO Service Product and Solutions
    • 2.10.4 Noble Life Sciences Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Noble Life Sciences Recent Developments and Future Plans
  • 2.11 Ergomed
    • 2.11.1 Ergomed Details
    • 2.11.2 Ergomed Major Business
    • 2.11.3 Ergomed Cell and Gene Therapy CRO Service Product and Solutions
    • 2.11.4 Ergomed Cell and Gene Therapy CRO Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Ergomed Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cell and Gene Therapy CRO Service Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Cell and Gene Therapy CRO Service by Company Revenue
    • 3.2.2 Top 3 Cell and Gene Therapy CRO Service Players Market Share in 2022
    • 3.2.3 Top 6 Cell and Gene Therapy CRO Service Players Market Share in 2022
  • 3.3 Cell and Gene Therapy CRO Service Market: Overall Company Footprint Analysis
    • 3.3.1 Cell and Gene Therapy CRO Service Market: Region Footprint
    • 3.3.2 Cell and Gene Therapy CRO Service Market: Company Product Type Footprint
    • 3.3.3 Cell and Gene Therapy CRO Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cell and Gene Therapy CRO Service Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Cell and Gene Therapy CRO Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Cell and Gene Therapy CRO Service Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Cell and Gene Therapy CRO Service Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Cell and Gene Therapy CRO Service Consumption Value by Type (2018-2029)
  • 6.2 North America Cell and Gene Therapy CRO Service Consumption Value by Application (2018-2029)
  • 6.3 North America Cell and Gene Therapy CRO Service Market Size by Country
    • 6.3.1 North America Cell and Gene Therapy CRO Service Consumption Value by Country (2018-2029)
    • 6.3.2 United States Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Cell and Gene Therapy CRO Service Consumption Value by Type (2018-2029)
  • 7.2 Europe Cell and Gene Therapy CRO Service Consumption Value by Application (2018-2029)
  • 7.3 Europe Cell and Gene Therapy CRO Service Market Size by Country
    • 7.3.1 Europe Cell and Gene Therapy CRO Service Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 7.3.3 France Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cell and Gene Therapy CRO Service Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Cell and Gene Therapy CRO Service Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Cell and Gene Therapy CRO Service Market Size by Region
    • 8.3.1 Asia-Pacific Cell and Gene Therapy CRO Service Consumption Value by Region (2018-2029)
    • 8.3.2 China Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 8.3.5 India Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Cell and Gene Therapy CRO Service Consumption Value by Type (2018-2029)
  • 9.2 South America Cell and Gene Therapy CRO Service Consumption Value by Application (2018-2029)
  • 9.3 South America Cell and Gene Therapy CRO Service Market Size by Country
    • 9.3.1 South America Cell and Gene Therapy CRO Service Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cell and Gene Therapy CRO Service Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Cell and Gene Therapy CRO Service Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Cell and Gene Therapy CRO Service Market Size by Country
    • 10.3.1 Middle East & Africa Cell and Gene Therapy CRO Service Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Cell and Gene Therapy CRO Service Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Cell and Gene Therapy CRO Service Market Drivers
  • 11.2 Cell and Gene Therapy CRO Service Market Restraints
  • 11.3 Cell and Gene Therapy CRO Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cell and Gene Therapy CRO Service Industry Chain
  • 12.2 Cell and Gene Therapy CRO Service Upstream Analysis
  • 12.3 Cell and Gene Therapy CRO Service Midstream Analysis
  • 12.4 Cell and Gene Therapy CRO Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cell and Gene Therapy CRO Service market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    Cell and Gene Therapy CRO (Contract Research Organization) Service refers to a service offered by a third-party organization that specializes in providing research and development support to companies involved in cell and gene therapy. This service may include cell line development, preclinical testing, clinical trial management, regulatory services, and product manufacturing to facilitate the development and commercialization of cell and gene therapies.
    The Global Info Research report includes an overview of the development of the Cell and Gene Therapy CRO Service industry chain, the market status of Hospital (Preclinical CRO, Clinical Stage CRO), Research Institute (Preclinical CRO, Clinical Stage CRO), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy CRO Service.
    Regionally, the report analyzes the Cell and Gene Therapy CRO Service markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy CRO Service market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Cell and Gene Therapy CRO Service market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy CRO Service industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Preclinical CRO, Clinical Stage CRO).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy CRO Service market.
    Regional Analysis: The report involves examining the Cell and Gene Therapy CRO Service market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy CRO Service market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Cell and Gene Therapy CRO Service:
    Company Analysis: Report covers individual Cell and Gene Therapy CRO Service players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell and Gene Therapy CRO Service This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Research Institute).
    Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy CRO Service. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy CRO Service areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy CRO Service market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Cell and Gene Therapy CRO Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Preclinical CRO
    Clinical Stage CRO
    Others
    Market segment by Application
    Hospital
    Research Institute
    Others
    Market segment by players, this report covers
    PPD
    Medpace
    Labcorp
    Veristat
    Charles River Laboratories
    Premier Research
    Catalent
    IQVIA
    Vial
    Noble Life Sciences
    Ergomed
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Cell and Gene Therapy CRO Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cell and Gene Therapy CRO Service, with revenue, gross margin and global market share of Cell and Gene Therapy CRO Service from 2018 to 2023.
    Chapter 3, the Cell and Gene Therapy CRO Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy CRO Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy CRO Service.
    Chapter 13, to describe Cell and Gene Therapy CRO Service research findings and conclusion.

    Buy now